Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$15.96 - $22.18 $3.11 Million - $4.33 Million
-195,000 Reduced 43.82%
250,000 $4.28 Million
Q2 2023

Aug 11, 2023

BUY
$15.65 - $24.1 $782,500 - $1.21 Million
50,000 Added 12.66%
445,000 $10.3 Million
Q1 2023

May 09, 2023

BUY
$17.48 - $29.09 $3.06 Million - $5.09 Million
175,000 Added 79.55%
395,000 $6.98 Million
Q4 2022

Feb 13, 2023

BUY
$17.09 - $27.91 $341,800 - $558,200
20,000 Added 10.0%
220,000 $5.98 Million
Q3 2022

Nov 14, 2022

SELL
$15.6 - $21.15 $299,426 - $405,953
-19,194 Reduced 8.76%
200,000 $3.45 Million
Q2 2022

Aug 03, 2022

BUY
$13.32 - $19.98 $721,864 - $1.08 Million
54,194 Added 32.84%
219,194 $3.83 Million
Q1 2022

May 12, 2022

BUY
$15.24 - $29.75 $990,600 - $1.93 Million
65,000 Added 65.0%
165,000 $2.8 Million
Q4 2021

Feb 02, 2022

BUY
$25.43 - $34.25 $254,300 - $342,500
10,000 Added 11.11%
100,000 $2.71 Million
Q2 2021

Aug 30, 2021

SELL
$28.5 - $39.37 $2.57 Million - $3.54 Million
-90,000 Reduced 50.0%
90,000 $3.46 Million
Q2 2021

Aug 13, 2021

BUY
$28.5 - $39.37 $3.11 Million - $4.29 Million
109,000 Added 153.52%
180,000 $6.92 Million
Q1 2021

May 10, 2021

BUY
$30.22 - $45.57 $710,170 - $1.07 Million
23,500 Added 49.47%
71,000 $2.17 Million
Q4 2020

Feb 16, 2021

BUY
$23.5 - $52.65 $1.12 Million - $2.5 Million
47,500 New
47,500 $1.81 Million

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $693M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.